Exicure (XCUR) Accounts Payables (2016 - 2026)
Exicure's (XCUR) quarterly Accounts Payables came in at $2.4 million in Q1 2026, up 102.07% YoY from $1.2 million in Q1 2025, and up 44.67% on a QoQ basis from $1.7 million in Q4 2025.
Exicure (XCUR) Accounts Payables (2016 - 2026) Analysis & Trends
Exicure (XCUR) has 11 years of Accounts Payables data on file, last reported at $2.4 million in Q1 2026.
- Quarterly Accounts Payables rose 102.07% year-over-year to $2.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $2.4 million (up 102.07% YoY) and the FY2025 annual result came in at $1.7 million, up 63.92% from the prior year.
- Accounts Payables climbed to $2.4 million in Q1 2026, from $1.7 million in the prior quarter.
- In the past five years, Accounts Payables ranged from a high of $2.4 million in Q1 2026 to a low of $343000.0 in Q2 2023.
- A 5-year average of $1.3 million and a median of $1.3 million in 2024 frame the typical range for Accounts Payables.
- Annual changes were most pronounced in 2022 — Accounts Payables tumbled 89.42% — and 2024, when it surged 362.1%.
- Tracing XCUR's Accounts Payables over 5 years: stood at $361000.0 in 2022, then soared by 351.8% to $1.6 million in 2023, then sank by 36.79% to $1.0 million in 2024, then jumped by 63.92% to $1.7 million in 2025, then soared by 44.67% to $2.4 million in 2026.
- The last three Accounts Payables figures came in at $2.4 million (Q1 2026), $1.7 million (Q4 2025), and $1.3 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Accounts Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 429.50 Mn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 1.16 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 1.52 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 167.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 470.30 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 108.02 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 622.65 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 428.93 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 35.57 Mn |
| 10 | Exicure | 7.27 Mn | 7.27 Mn | - | 2.19 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.45 Mn |
| Dec 31, 2025 | 1.69 Mn |
| Sep 30, 2025 | 1.31 Mn |
| Jun 30, 2025 | 1.84 Mn |
| Mar 31, 2025 | 1.21 Mn |
| Dec 31, 2024 | 1.03 Mn |
| Sep 30, 2024 | 1.34 Mn |
| Jun 30, 2024 | 1.59 Mn |
| Mar 31, 2024 | 1.83 Mn |
| Dec 31, 2023 | 1.63 Mn |
| Sep 30, 2023 | 865,000.00 |
| Jun 30, 2023 | 343,000.00 |
| Mar 31, 2023 | 452,000.00 |
| Dec 31, 2022 | 361,000.00 |
| Sep 30, 2022 | 920,000.00 |
| Jun 30, 2022 | 1.59 Mn |
| Mar 31, 2022 | 1.92 Mn |
| Dec 31, 2021 | 3.41 Mn |
| Sep 30, 2021 | 2.49 Mn |
| Jun 30, 2021 | 2.25 Mn |